-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Hold on Fate Therapeuticsto Hold

Benzinga·06/12/2025 12:27:54
Listen to the news
Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:FATE) from Hold to Hold.